Capital

The traditional process of investing in private funds is tedious, difficult, and expensive. Velvet makes private funds simple and transparent and saves investors time by listing funds at scale, automating diligence, and simplifying the investment process. Velvet helps you easily discover funds, connect with managers, evaluate track records, and make investments on behalf of clients or yourself.

Velvet curates hedge funds, venture capital, private credit, and private equity at scale with a listings platform that was designed with the LP in mind and makes it easy to find funds based on mandates, categories, fund types, asset exposure, size, returns, and more.

Velvet supports investments from authorized third parties investing on behalf of entities and individuals for investment advisors, family offices, endowments, pension funds, trusts, fund-of-funds, and other institutional clients.

OrbitalIQ is a premier customer enablement technology ecosystem that gives consumers of all venue sizes and operations a one-of-a-kind experience starting with the ticket purchase and continuing through an enhanced event participation. 

Orbital aims to bridge the gap between traditional financial services and digital assets through its corporate treasury platform offering. 

The complete suite of Orbital IQ products and services consists of enhanced ticketing solutions, online and on-site, that continue throughout the venue, complete integrated POS systems, digital wallets and wearables to create the ultimate buying experience, and a CRM that provides thoughtful customer analytics. 

Orbital is a London headquartered fintech company centred around a treasury solutions platform aimed at large multinational corporates. The company’s offering is made up of multi-currency IBAN accounts, international payments and FX, digital asset vaults, trading and liquidity, and crypto-commerce C2B payments through one interface.

DIAMANTE (Nano-Technologies for Autoimmune Disease) is a biotech company focused on the use of plants for producing high value-added molecules.

The company was funded in 2016 with the development of new tools in autoimmune disease diagnosis and now we are growing approaching therapeutics applications.

As an innovation-oriented female-led company, our value proposition is the creation of novel therapeutic approaches for autoimmune diseases based on the restoration of self-tolerance, using plant viruses displaying immunodominant peptides.

The company’s main asset is a specific therapeutic solution for Rheumatoid Arthritis (RA). Diamante’s technology leverages plant viruses for the production of virus nanoparticles (VNPs) and an innovative therapeutic approach based on the specific induction of the immunological tolerance through the use of specific autoantigenic peptides. We have pre-clinical evidence of the efficacy of our therapeutic approach and our goal is to enter the human clinical trials by the end of 2023. We are looking for industrial partners to grow together. Diamante’s pipeline will explore new therapeutic applications for other autoimmune diseases.

THE PREMIER TRADING SOLUTION FOR PRIVATE COMPANIES AND INVESTORS

ClearList establishes real-time, transparent price discovery based on actual investor sentiment. We are the first and final step for a seamless and successful transition to the public market.

Broad Investor Demand
ClearList offers access to a vast network of investors interested in investing in successful private companies. Even before trading, ClearList hosts a digital roadshow inviting private companies to market themselves to 400+ family offices and institutional buyers. ClearList’s extensive ecosystem of strategic partners and potential investors offers unrivaled opportunities.

Empowering Private Companies
ClearList is issuer-centric. Private companies traded on ClearList control the full investment process for their private securities, employees, and investors. Through the superior trading technology of ClearList, investors have direct access to private securities with drastically reduced fees and without ever having to leave ClearList’s secure platform. ClearList empowers private companies to develop a liquid market for their securities, while preparing for a listing in the public markets.

Accelerating The Path to A Public Listing
ClearList has been developed by GTS, the largest Designated Market Maker at the New York Stock Exchange and #1 in IPOs at the NYSE for five years running. The advanced pricing technology of GTS has made it one of the largest traders of public securities in the world. ClearList utilizes GTS’ technology to create a ClearPrice in private company securities. The ClearPrice is the real-time fair value of securities traded on ClearList and transmitted to qualified investors continuously. ClearList’s ability to display the best prices with the lowest fees to investors helps ensure ample liquidity for the buying and selling of securities.

Powerful Medical leads one of the most important shifts in modern medicine — to augment human-made clinical decisions with artificial intelligence. 

Our research-validated and certified AI system empowers healthcare professionals in their daily decision-making and provides accurate diagnoses and individualized treatment recommendations. Thousands of healthcare professionals in Europe are using our technology every day to enhance their patient care.  

At Powerful Medical, we believe that the transition from purely human-made clinical decisions to decisions augmented by Artificial Intelligence is one of the most important shifts in modern medicine.

Using Big Data, Machine Learning, and other breakthrough techniques, we want to empower every physician with the right tools to give patients the most reliable diagnosis and treatment possible.

Powerful Medical is a medical company backed by 28 world-class cardiologists that are led by our expert Scientific Board with decades of experience in both daily patient care as well as clinical research and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

A livestream shopping platform that brings brands and influencers together to recreate the online shopping experience by empowering the story of your brand.

Our platforms, Terrific.Live, creates shared customer experiences by allowing shoppers to join real-time, interactive product sessions with their favorite Influencers, receive discounts when purchasing with friends, and enjoy deeper relationships with brands.

Combining the online and in-store dimensions, our uniquely interactive social features closely resemble the real-world experience of shopping with friends – with an economic twist. Shoppers receive group-driven discounts based on the number of buyers per purchase, incentivizing them to join product sessions with friends and purchase items together. 

Many products require particular know-how in order to be used properly or purchased wisely. A real-time assisted shopping experience, our product provides shoppers the ability to make educated item purchases with an understanding of how to best use them. 

NGT HealthCare II (“NGT”) is an early-stage medical device and life sciences venture capital fund, investing in promising technologies.

NGT enjoys a very significant risk reduction mechanism, by means of high non-dilutive leverage via Israel’s Innovation Authority (“IIA”). Close relationships with many of Israel’s leading universities, hospitals, and research institutions provide NGT with a rich flow of investment opportunities and a wide network of multinational corporations that further enables NGT to create value for its portfolio companies. NGT is structured as an impact fund, located in Nazareth, aligned with 3 UN SDGs.

NGT focuses on a “triple” bottom line by:

• Developing and creating value for cutting-edge medical technologies and startup companies
• Providing high financial returns for our partners and investors
• Fostering a social agenda of inclusion and multicultural collaboration

One of NGT’s social agenda goals is to develop and improve the economic potential, and by extension the socioeconomic situation of Arabs citizens of Israel, by providing the infrastructure for launching and funding early-stage life sciences and medical device companies.

NGT’s impact investment model includes working together with entrepreneurs and scientists from both the Arab and Jewish societies, and from the Israeli and international business communities.

BOH was founded in 2020 with a clear mission: to detect cancer in patients and help them receive the optimal treatment medicine can offer. We aim to improve existing cancer screening programs through the commercialization of our proven disease detection method. We leverage AI to detect, in real-time, a broad range of cancerous biomarkers alone.

Our proprietary AI technology enables rapid breath sample analysis designed to answer and improve patient outcomes through quality monitoring and analytics. Screening healthy, high-risk groups can help detect cancer earlier and open up greater opportunities for treatment and treatment design. Current screening tests play a role to some extent in some cancers, but all screening tests have limitations and improved screening methods are urgently needed. Unfortunately, for many types of cancer, there are still no effective screening recommendations, or the benefits of screening tests are negligible compared to the potential harm.

• A breath sample contains more than 3,000 molecules that provide relevant clinical information
• BOH detects over 1,000 molecules that can be correlated to gold-standard diagnostics such as biopsy for cancer
• BOH detects non-volatile, semi & volatile molecules
• Breath tests showed in previous research very high sensitivity and specificity values for Non-Communicable Diseases (NCDs), especially cancer

Mobi is revolutionizing mobility for cities by equipping them with an AI-powered platform to understand mobility patterns, optimize traffic flow, and reduce congestion by >30% across any road network. With rising driver frustration, increasing economic loss from traffic jams, and diminishing air quality from vehicle emissions, transportation authorities have come to understand that building more roads is not the answer and offering alternative modes of transport is simply not enough. The only solution is for cities to fundamentally transform how traffic is managed across a road network. It’s about transforming traffic operations from simply reacting to congestion after it occurred to proactively monitoring the entire road network and predicting/preempting congestion from ever happening in the first place.

Mobi has created a solution to support this traffic management transformation for both cities and business operators impacted by chronic congestion in high-demand areas of interest.
We’ve developed a turnkey, AI-powered SaaS solution that equips policymakers, transportation planners, and traffic controllers with the ability to proactively manage today’s road network and be prepared for tomorrow’s connected vehicle ecosystem. With real-time predictive alerts, optimization algorithms, and AI (Artificial Intelligence) actionable insights, the platform enables to detect emerging gridlocks, pinpoint their root cause, and take preemptive actions to unlock the grid.

The company has proven commercial success operating in several cities around the world, is at the forefront of innovation in a market valued at tens of billions of dollars a year.
Whether it’s understanding trip patterns and crowds forming to help the State of Israel slow the spread of the COVID-19 virus or predicting and preventing vehicle congestion in Downtown Atlanta in the USA, Mobi is poised to revolutionize mobility for cities across the globe.

Mobi’s team is comprised of experts in business, technology, AI, product development and traffic engineering. Mobi is focused on expanding its operations in the US market.
The current fundraising round will allow it to close a large pipeline of customer opportunities in the US market. Closing these initial US customers will significantly increase the company’s value and help complete an A round from a leading strategic investor within a year.

Elvy.ai is a sleep-tech company that develops solutions to improve people’s health and performance during the day by providing a safer and sounder sleep and an overall healthy lifestyle. Elvy’s flagship product is a wireless mobile phone charger that protects users from radiation and blue light without impairing the functionality of the mobile phone. Elvy Charger allows you to charge your mobile phone by your bed, but without fear of damaging your health and quality of sleep. Elvy Charger promotes healthy phone habits and reduces exposure to radiation, leading to better sleep and improved health and well-being. Elvy.ai plans to develop further products that promote sleep hygiene.

Elvy.ai promotes overall wellness by looking after the quality of your sleep. Just as our families are safer and healthier using Elvy Charger, we want you and your loved ones to sleep better and enjoy a healthier lifestyle, creating a positive change. We believe that Elvy.ai’s wireless charger will become a standard household item worldwide and will charge phones while improving the quality of sleep.      

Founded by a Family Office, created and designed for Family Offices, and owned by Family Offices, ShareNett is a members-only global network of professional investors collaborating on curated, quality investment opportunities.       

Membership is diverse by design, powering a global network to facilitate peer-to-peer investing. Global network members’ preeminent domain expertise is deployed to source, due diligence, sponsor, and syndicate leading opportunities in the alternative investment universe. All investments are discretionary and voluntary, made individually and directly.

ShareNett’s secure and regulatory-compliant platform provides a trusted and collaborative environment for members to share actionable investment ideas, content, relationships, and resources. Membership to ShareNett is by invitation only.

Leading the digital investment revolution, our software platform provides an end-to-end solution for all participants in private investments. Trellis simplifies the investment process by transforming it into an automated workflow that connects everyone involved, including issuers, intermediaries, and inventors. 

We offer a Transactional Services solution package that provides everything you require for a smooth and efficient transaction. From inception to completion, this suite of microservices will make your entire transaction process effortless.

Our software provides four specialized portals that lead to one global solution. Trellis Raise organizes and presents issuer due-diligence information to Trellis Show, which provides a detailed overview of the investment opportunity, including a data room, communications, and all needed documents required to complete the transaction. Trellis Review supports all investor needs for seeking diligence-ready deal flow, allowing for the ability to complete KYC and monitor transactions, while Trellis Invest gives the ability to review, analyze, and invest in fiduciary-approved deal flow. All without every having to leave the Trellis platform. 

Guesty is a property management platform for short-term and vacation rentals. Its end-to-end solution simplifies the complex operational needs that property managers face on a daily basis – from guest communication to task assignment to payment processing, allowing property managers to save time and focus on business growth. The platform’s database includes information about guests, reservations, listings and staff, teams’ work schedules, automation tools, and 24/7 guest communication.

With Guesty’s automation tools, we become your answering machine. Create auto-responses that handle your most time-consuming, routine messages and we’ll automatically send them out based on the triggers you set for us. From check-in and check-out instructions to sequences of follow-up messages such as review requests, you won’t believe how much time and trouble you save when you automate these interactions.